119 related articles for article (PubMed ID: 8713696)
21. Characterization and quantification of plasma proteins excreted in faeces from healthy humans.
Schmidt PN; Blirup-Jensen S; Svendsen PJ; Wandall JH
Scand J Clin Lab Invest; 1995 Feb; 55(1):35-45. PubMed ID: 7624735
[TBL] [Abstract][Full Text] [Related]
22. Enteric alpha-1-antitrypsin loss and comparison with Okokit II and Haemoccult for the detection of colorectal cancer.
Moran A; Hendrickse C; Jones AF; Neoptolemos J
Surg Oncol; 1994 Jun; 3(3):147-51. PubMed ID: 7952398
[TBL] [Abstract][Full Text] [Related]
23. Faecal clearance of alpha 1-antitrypsin reflects disease activity and correlates with rapid turnover proteins in chronic inflammatory bowel disease.
Miura S; Yoshioka M; Tanaka S; Serizawa H; Tashiro H; Asakura H; Tsuchiya M
J Gastroenterol Hepatol; 1991; 6(1):49-52. PubMed ID: 1909193
[TBL] [Abstract][Full Text] [Related]
24. Highly sensitive faecal DNA testing of TWIST1 methylation in combination with faecal immunochemical test for haemoglobin is a promising marker for detection of colorectal neoplasia.
Suehiro Y; Zhang Y; Hashimoto S; Takami T; Higaki S; Shindo Y; Suzuki N; Hazama S; Oka M; Nagano H; Sakaida I; Yamasaki T
Ann Clin Biochem; 2018 Jan; 55(1):59-68. PubMed ID: 28081635
[TBL] [Abstract][Full Text] [Related]
25. Fecal loss and clearance of alpha-1-antitrypsin in children with persistent diarrhea.
Duarte MA; Carneiro SM; Melo MC; Penna FJ
Braz J Med Biol Res; 1994 Jul; 27(7):1553-60. PubMed ID: 7874022
[TBL] [Abstract][Full Text] [Related]
26. Protein-losing enteropathy and hypoalbuminemia in AIDS.
Laine L; Garcia F; McGilligan K; Malinko A; Sinatra FR; Thomas DW
AIDS; 1993 Jun; 7(6):837-40. PubMed ID: 8363760
[TBL] [Abstract][Full Text] [Related]
27. Simplified determination of intestinal protein excretion based on alpha 1-antitrypsin clearance.
Karbach U; Singe CC; Ewe K
Z Gastroenterol; 1988 Mar; 26(3):169-73. PubMed ID: 3261475
[TBL] [Abstract][Full Text] [Related]
28. Faecal parameters in the assessment of activity in inflammatory bowel disease.
van der Sluys Veer A; Biemond I; Verspaget HW; Lamers CB
Scand J Gastroenterol Suppl; 1999; 230():106-10. PubMed ID: 10499470
[TBL] [Abstract][Full Text] [Related]
29. Measurement of occult upper gastrointestinal tract blood loss: a direct comparison of radiochromium and haem-porphyrin assay techniques.
Young GP; St John DJ; Lynch NM; McHutchison JG; Barraclough D
J Gastroenterol Hepatol; 1993; 8(4):328-33. PubMed ID: 8374088
[TBL] [Abstract][Full Text] [Related]
30. Fecal alpha1-proteinase inhibitor concentration in dogs with chronic gastrointestinal disease.
Murphy KF; German AJ; Ruaux CG; Steiner JM; Williams DA; Hall EJ
Vet Clin Pathol; 2003; 32(2):67-72. PubMed ID: 12833220
[TBL] [Abstract][Full Text] [Related]
31. Faecal retention: a common cause in functional bowel disorders, appendicitis and haemorrhoids--with medical and surgical therapy.
Raahave D
Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748875
[TBL] [Abstract][Full Text] [Related]
32. Technical report: results of immunological tests on faecal extracts are likely to be extremely misleading.
Ferguson A; Humphreys KA; Croft NM
Clin Exp Immunol; 1995 Jan; 99(1):70-5. PubMed ID: 7813112
[TBL] [Abstract][Full Text] [Related]
33. Fecal alpha 1-antitrypsin measurement: an indicator of Crohn's disease activity.
Meyers S; Wolke A; Field SP; Feuer EJ; Johnson JW; Janowitz HD
Gastroenterology; 1985 Jul; 89(1):13-8. PubMed ID: 3874110
[TBL] [Abstract][Full Text] [Related]
34. Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome.
Kaiser T; Langhorst J; Wittkowski H; Becker K; Friedrich AW; Rueffer A; Dobos GJ; Roth J; Foell D
Gut; 2007 Dec; 56(12):1706-13. PubMed ID: 17675327
[TBL] [Abstract][Full Text] [Related]
35. Faecal haemoglobin concentration is related to detection of advanced colorectal neoplasia in the next screening round.
Digby J; Fraser CG; Carey FA; Diament RH; Balsitis M; Steele RJ
J Med Screen; 2017 Jun; 24(2):62-68. PubMed ID: 27370211
[TBL] [Abstract][Full Text] [Related]
36. Fecal alpha1-antitrypsin concentrations as a measure of enteric protein loss after modified fontan operations.
Fujii T; Shimizu T; Takahashi K; Kishiro M; Ohkubo M; Akimoto K; Yamashiro Y
J Pediatr Gastroenterol Nutr; 2003 Nov; 37(5):577-80. PubMed ID: 14581800
[TBL] [Abstract][Full Text] [Related]
37. [A double immunochemical method for detecting faecal haemoglobin and albumin in rectal screening].
Tarpay A; Szabadosné Németh M; Orosz E; Kásler M; Burai M; Pap A; Ottó S
Magy Onkol; 2011 Nov; 55(4):268-73. PubMed ID: 22128309
[TBL] [Abstract][Full Text] [Related]
38. [Increased serum alpha 1-antitrypsin does not produce a rise in fecal alpha 1-antitrypsin in patients with healthy intestines].
Stufler MH; Ewe K; Gierlasinski B; Prün H; Zutt M
Z Gastroenterol; 1991 Jan; 29(1):11-5. PubMed ID: 2058223
[TBL] [Abstract][Full Text] [Related]
39. Faecal calprotectin levels in a high risk population for colorectal neoplasia.
Kronborg O; Ugstad M; Fuglerud P; Johne B; Hardcastle J; Scholefield JH; Vellacott K; Moshakis V; Reynolds JR
Gut; 2000 Jun; 46(6):795-800. PubMed ID: 10807890
[TBL] [Abstract][Full Text] [Related]
40. Plasma Cytokeratin 18 and fecal Alpha-1 Antitrypsin concentrations in dogs with osteosarcoma receiving carboplatin chemotherapy.
Taikowski K; Rudinsky AJ; Louke DS; Warry E; Fenger JM
Vet Med Sci; 2021 Mar; 7(2):385-392. PubMed ID: 33222415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
